Skip to main content

Advertisement

Figure 2 | Stem Cell Research & Therapy

Figure 2

From: A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

Figure 2

Changes in glycated hemoglobin, fasting glucose and 2 h postprandial glucose levels during the 12-month study period. A: The changes in glycated hemoglobin levels between baseline and 1, 3, 6 and 12 months. B: Changes in fasting glucose and 2 h postprandial glucose levels between baseline and 1, 3, 6 and 12 months. The results are shown as the mean ± S.D. *P <0.05 compared with pretreatment; **P <0.01 compared with pretreatment.

Back to article page